HF
BNTX icon

HRT Financial’s BioNTech BNTX Stock Holding History

HRT Financial’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,500
Closed -$3.57M – 3832
2025
Q4 		$3.57M Buy
+37,500
New +$3.78M 0.01% 954
2022
Q4 		– Sell
-1,500
Closed -$202K – 2491
2022
Q3 		$202K Buy
+1,500
New +$229K ﹤0.01% 2205
2022
Q2 		– Sell
-6,600
Closed -$1.13M – 2964
2022
Q1 		$1.13M Buy
+6,600
New +$1.11M 0.01% 943
2021
Q4 		– Sell
-1,800
Closed -$491K – 3221
2021
Q3 		$491K Buy
+1,800
New +$572K ﹤0.01% 2009

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's BNTX Position: Q1 2026 in Review

HRT Financial sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 7,213 shares — an estimated $686K sold.

HRT Financial first reported a position in BNTX in Q2 2022 and held it in 6 quarters. The position peaked at $3.64M in Q3 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • HRT Financial reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 7,213 BioNTech shares in Q1 2026, an estimated $686K.
  • HRT Financial first reported a position in BioNTech in Q2 2022 and held it in 6 quarters.
  • HRT Financial's BioNTech position peaked at $3.64M in Q3 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.